MORRIS PLAINS, N.J., April 26 /PRNewswire/ -- Skila, A Sela2 Company, announces the launch of iIntelligence, the next generation of its unique solutions for optimizing sales and marketing effectiveness. Developed specifically for the pharmaceutical and life sciences industries, iIntelligence enables global organizations to effectively manage competitive intelligence and more quickly leverage it for more strategic decision making.

An increasingly competitive and rapidly changing global market makes competitive intelligence a critical function in any successful organization. While it is a recognized need among pharmaceutical and biotech companies, many organizations are still utilizing reactive models which rely on individuals to seek out information in response to events that have already taken place.

iIntelligence helps organizations proactively monitor competitive intelligence, collecting information from external sources as well as from within an organization's own internal network. Skila's Pull Through Services help to facilitate communication and collaboration among individuals and teams, pushing relevant information in front of key decision makers. Intelligence briefs and red alerts delivered with brand implications allow managers to quickly assess situations and transform information into action. By integrating competitive intelligence into brand management workflows, stakeholders at every level of the organization can make informed, strategic decisions.

iIntelligence helps managers take a proactive approach to manage threats and exploit opportunities. The ability to transform information into action lends easily to developing predictive models crucial to creating or maintaining competitive advantage. The early warning mechanisms that iIntelligence employs enable even large organizations to remain flexible. iIntelligence also provides the necessary infrastructure and support services to capture and retain organizational knowledge and promote best practices on both a local and global scale.

"Research shows that 70-80 percent of competitive intelligence can be found within one's own organization. With iIntelligence, we are very excited to offer our clients a powerful combination of technology and services to effectively share and communicate this knowledge to aid strategy and action," commented Moish Tov, CEO of Skila. "Our mission is to provide best-in-class solutions that enable pharmaceutical companies to rapidly respond to today's critical business challenges. We feel that iIntelligence can give pharmaceutical companies a strategic and competitive advantage in a rapidly changing global market."

About Skila

Skila is a customer-driven company and a leader in developing best-in- class knowledge-driven management solutions for the pharmaceutical industry. Skila's solutions help the pharmaceutical industry increase their marketing and brand effectiveness and have been adopted by many of the leading companies in the industry, such as: Boehringer Ingelheim, Roche, Eli Lilly & Company, Allergan, and Johnson & Johnson.

Utilizing expert services, unique methodology and its Intelligration(R) technology, Skila's solutions integrate critical information communicating it to the right people, at the right time through a "Single Touch Point." These solutions are vital to pharmaceutical organizations in successfully managing common business challenges such as:

    * Optimizing product launches
    * Maximizing the impact of strategic alliances with marketing partners
    * Effectively managing competitive intelligence for strategic advantage
    * Maximizing share of mind with key opinion leaders
    * Synchronizing measurement and performance of global brand teams
    * Maximizing effectiveness between marketing, sales, and medical teams

To receive more information, please call (973) 889-1300 and ask for Business Development, or email .

You can also visit Skila on the web at http://www.skila.com.

SOURCE Skila